Cefdinir is an effective antibiotic for bacterial sinus infections, with clinical cure rates around 87% to 91% in large trials. It’s not the first drug most doctors reach for, though. Guidelines recommend it primarily as an alternative when a patient can’t take amoxicillin or amoxicillin-clavulanate, which remain the preferred first-line treatments.
How Cefdinir Compares to First-Line Options
Amoxicillin (or amoxicillin-clavulanate, the combination version) is the standard first choice for acute bacterial sinusitis. Cefdinir performs nearly as well. Two large randomized trials comparing the two found that cefdinir cured about 90% of patients when evaluated one to two weeks after finishing treatment, while amoxicillin-clavulanate cured about 91%. That gap is not statistically significant.
At a longer follow-up of three to five weeks, the numbers held steady. Cefdinir taken once daily actually showed a 94% response rate among patients with confirmed bacterial infections, compared to 92% for amoxicillin-clavulanate. In practical terms, the two antibiotics perform in the same ballpark for most people with a straightforward sinus infection.
So why isn’t cefdinir first-line? Amoxicillin is cheaper, has decades of safety data, and covers the most common sinus pathogens reliably. Cefdinir is a third-generation cephalosporin, a broader-spectrum drug, and using narrow-spectrum antibiotics when they work helps slow the development of antibiotic resistance.
When Doctors Prescribe Cefdinir Instead
The most common reason you’d be prescribed cefdinir for a sinus infection is a penicillin allergy. The 2022 guidelines from the American Academy of Allergy, Asthma, and Immunology specifically recommend cefdinir for patients who have had allergic reactions to amoxicillin, penicillin, or cephalexin, because it doesn’t share the same chemical structure that triggers those reactions. The cross-reactivity rate between penicillins and third-generation cephalosporins like cefdinir is less than 1%.
Your doctor might also choose cefdinir if you’ve recently taken amoxicillin and it didn’t resolve your symptoms, or if local resistance patterns in your area make amoxicillin a less reliable choice.
What Cefdinir Targets
Bacterial sinus infections are typically caused by three organisms: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Cefdinir is active against all three. It works by disrupting the process bacteria use to build their cell walls, which causes the cells to break apart and die.
One advantage cefdinir has is stability against beta-lactamases, enzymes that some bacteria produce to destroy antibiotics. It resists breakdown by 13 of the most common beta-lactamases, which makes it useful when the infection involves bacteria that have developed this particular defense mechanism. This is especially relevant for H. influenzae and M. catarrhalis strains, which frequently produce these enzymes.
Dosing and How Long Treatment Lasts
Adults and teenagers typically take 300 mg twice a day or 600 mg once a day. Treatment courses run 5 to 10 days, with 10 days being more common for sinus infections. For children aged 6 months to 12 years, dosing is weight-based, calculated by a pediatrician, with a maximum of 600 mg per day.
Most people notice their symptoms start improving within the first two to three days of treatment, though full resolution often takes longer. It’s important to finish the entire course even if you feel better early, because stopping short can leave enough bacteria alive to cause a relapse or contribute to resistance.
Side Effects and the Red Stool Surprise
Cefdinir’s side effect profile is similar to most oral antibiotics. Diarrhea, nausea, and stomach discomfort are the most common issues. But there’s one side effect that catches people off guard: bright red or rust-colored stool.
This happens when cefdinir or its breakdown products react with iron in the digestive tract, forming a reddish compound. It’s completely harmless and stops once you finish the antibiotic. However, if you’re taking an iron supplement, the interaction does more than change stool color. An iron supplement containing 60 mg of elemental iron can reduce cefdinir absorption by 80%, which could seriously undermine the antibiotic’s effectiveness. Multivitamins with 10 mg of iron reduce absorption by about 31%.
If you need to take iron while on cefdinir, separate the two by at least two hours. Iron-fortified foods at typical levels (like infant formula) don’t cause a meaningful interaction and are fine to consume alongside the medication.
What to Avoid While Taking Cefdinir
Beyond iron supplements, antacids containing aluminum or magnesium can also interfere with how well your body absorbs cefdinir. If you take antacids regularly, space them at least two hours apart from your antibiotic dose. The same timing rule applies to any supplement or medication containing iron or these minerals.
Cefdinir is taken by mouth as either a capsule or a liquid suspension. It can be taken with or without food, which makes it relatively convenient compared to some antibiotics that require an empty stomach. If you’re given the liquid form, keep it refrigerated and shake it well before each dose.
Is It the Right Choice for Your Sinus Infection?
Not every sinus infection needs antibiotics in the first place. Most sinus infections are viral and will resolve on their own within 7 to 10 days. Antibiotics only help when the infection is bacterial, which doctors typically suspect when symptoms last beyond 10 days without improvement, when symptoms are severe (high fever with facial pain and thick nasal discharge for at least 3 to 4 consecutive days), or when symptoms initially improve and then suddenly worsen.
If your doctor determines you do need an antibiotic and prescribes cefdinir, the evidence supports that it works well. Its cure rates are comparable to the first-line options, it covers the bacteria most likely causing your infection, and it’s generally well tolerated. It’s a solid second-line choice, particularly if penicillin-based antibiotics aren’t an option for you.